Skip to main content

Table 1 Sociodemographic, clinical and laboratory characteristics of Rheumatoid Arthritis patients of the REAL study [19]

From: Cardiovascular risk comorbidities in rheumatoid arthritis patients and the use of anti-rheumatic drugs: a cross-sectional real-life study

Variables n (%)
Gender (n = 1116)
 Female 998 (89.4)
Age – Mean (standard deviation) (n = 1116) 55.15 (21–88)
Education time (years) (n = 1076)
 0–4 years 301 (28)
 5–11 years 629 (58.4)
  ≥ 12 years 146 (13.6)
Disease duration (years) – mean (standard deviation) (n = 1116) 14.58 (1–57)
Erosive disease (n = 1096)
 Yes 602 (54.9)
DAS 28 VSH Scorea mean (standard deviation) 3.62 (0–8)
Smoking (n = 1116)
 Smoker 121 (10.8)
 Former Smoker 320 (28.7)
 Never Smoked 675 (60.5)
Rheumatoid Factor (n = 1098)
 Positive 863 (78.6)
ACPAb (n = 479)
 Positive 368 (768)
  1. aDisease Activity Score Index-28 Joints (DAS28); b Anti-citrullinated peptide antibody